Market revenue in 2023 | USD 336.3 million |
Market revenue in 2030 | USD 528.7 million |
Growth rate | 6.7% (CAGR from 2023 to 2030) |
Largest segment | Synthetic |
Fastest growing segment | Biotech |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Synthetic, Biotech |
Key market players worldwide | Basf SE, CordenPharma, Bristol-Myers Squibb Co, Pfizer Inc, Boehringer Ingelheim Pharma, Dr. Reddy’s Laboratories, Sun Pharmaceutical Industries, Albany Molecular Research, Sanofi SA, Lonza Group Ltd, Cipla Ltd DR, Merck & Co Inc, Teva Pharmaceutical Industries Ltd, Novartis AG ADR, Roche Holding AG |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to high potency active pharmaceutical ingredients market will help companies and investors design strategic landscapes.
Synthetic was the largest segment with a revenue share of 73.62% in 2023. Horizon Databook has segmented the Mexico high potency active pharmaceutical ingredients market based on synthetic, biotech covering the revenue growth of each sub-segment from 2018 to 2030.
According to the International Agency for Research o n Cancer, i n 2012, 148,000 people are diagnosed with cancer every year i n Mexico and the incidence rate per 100,000 people per year is 131.5. The number of cases reached to 190,667 per year in 2018.
Moreover, biotechnology and biopharmaceutical industries have grown in the country owing to increasing number of start-ups and rising investments, which is anticipated t o fuel the market growth. Factors such as unhealthy dietary patterns, physical inactivity, and insufficient awareness about lifestyle-induced disorders are responsible for the increasing disease incidence.
Horizon Databook provides a detailed overview of country-level data and insights on the Mexico high potency active pharmaceutical ingredients market , including forecasts for subscribers. This country databook contains high-level insights into Mexico high potency active pharmaceutical ingredients market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
No related regions found.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account